• Profile
Close

Oncologic safety of prophylactic nipple-sparing mastectomy in a population with BRCA mutations: A multi-institutional study

JAMA Surgery Feb 27, 2018

Jakub JW, et al. - In this study, the oncologic safety of nipple-sparing mastectomy (NSM) was reported and evidence-based data were provided to patients and health care professionals regarding preservation of the nipple-areolar complex during a risk-reducing mastectomy in a population with BRCA mutations. It was observed that in a BRCA population, nipple-sparing mastectomies are highly preventive against breast cancer. It was recommended offering NSM as a breast cancer risk–reducing strategy to appropriate patients with BRCA mutations.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay